Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Resource Type
Article
Authors
Middleton, Gary ; Silcocks, Paul ; Cox, Trevor ; Valle, Juan ; Wadsley, Jonathan ; Propper, David ; Coxon, Fareeda ; Ross, Paul ; Madhusudan, Srinivasan ; Roques, Tom ; Cunningham, David ; Falk, Stephen ; Wadd, Nick ; Harrison, Mark ; Corrie, Pippa ; Iveson, Tim ; Robinson, Angus ; McAdam, Karen ; Eatock, Martin ; Evans, Jeff ; Archer, Caroline ; Hickish, Tamas ; Garcia-Alonso, Angel ; Nicolson, Marianne ; Steward, William ; Anthoney, Alan ; Greenhalf, William ; Shaw, Victoria ; Costello, Eithne ; Naisbitt, Dean ; Rawcliffe, Charlotte ; Nanson, Gemma ; Neoptolemos, John
Source
In Lancet Oncology July 2014 15(8):829-840
Subject
Primary Research Articles
Language
ISSN
1470-2045